NDAQ insider Jeremy Skule files Form 144 for 2,105-share sale on 10/01/2025
Rhea-AI Filing Summary
Form 144 notice filed for NDAQ. The filer reports a planned sale of 2,105 common shares through Morgan Stanley Smith Barney on 10/01/2025 with an aggregate market value of $185,703.10. These shares were originally issued as performance shares by the issuer on 02/20/2024 and fully paid on the same date. The filing also discloses two prior sales by the same person: 2,105 shares sold on 09/02/2025 for $196,228.10 and 2,105 shares sold on 08/01/2025 for $201,006.45. The seller is identified as Jeremy Skule at the provided address.
Positive
- Securities were granted as performance shares (02/20/2024), indicating compensation alignment with issuer performance
- Broker-dealer identified (Morgan Stanley Smith Barney) and specific sale date provided (10/01/2025), meeting disclosure requirements
Negative
- None.
Insights
TL;DR: Insider filing shows scheduled sale of 2,105 NDAQ shares originally granted as performance shares.
The Form 144 indicates a planned off-exchange/transaction through Morgan Stanley Smith Barney for 2,105 common shares valued at $185,703.10, following two recent sales of identical share amounts in August and September 2025. The shares were acquired as performance-based compensation on 02/20/2024. This is a routine Rule 144 notice documenting an insider sale and prior transactions; the form does not state any change in issuer operations or provide additional financial metrics.
TL;DR: Filing is standard Rule 144 notice with required seller representation and trading-plan disclaimer language.
The document contains the required certification that the seller is not aware of undisclosed material information and notes Rule 10b5-1 plan consideration fields. It lists broker details, acquisition date, nature of acquisition, and prior sales in the last three months. No allegations, regulatory actions, or material adverse facts are disclosed in this filing.